BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/30/0.1/21.06.24 Share Price

Warrant

9ZLNB

NLBNPFR1WXF1

Market Closed - Euronext Paris 17:30:02 15/05/2024 BST
0.045 EUR +80.00% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/30/0.1/21.06.24
Current month+75.00%
1 month+40.00%
Date Price Change
15/05/24 0.045 +80.00%
14/05/24 0.025 -28.57%
13/05/24 0.035 +40.00%
10/05/24 0.025 0.00%
09/05/24 0.025 0.00%

Real-time Euronext Paris

Last update May 15, 2024 at 05:30 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
9ZLNB
ISINNLBNPFR1WXF1
Date issued 15/12/2023
Strike 30 $
Maturity 21/06/2024 (37 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.245
Lowest since issue 0.01
Spread 0.01
Spread %20.00%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.38 USD
Average target price
31.94 USD
Spread / Average Target
+12.54%
Consensus
  1. Stock Market
  2. Warrants
  3. 9ZLNB Warrant